The 30-year program has tracked and compiled data on diabetes prevention, treatment, and outcomes, providing a foundation and insights for international research.

ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment

By Grace Halsey

March 19th 2025

The amylin analog at 5 doses will be compared with placebo when added to a reduced calorie diet and increased physical activity regimen for 42 weeks, said Zealand Pharma.

Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals

By Grace Halsey

March 18th 2025

Three of the 5 osteoporosis screening tools recommended by the USPSTF for identifying osteoporosis in postmenopausal women aged 50 yo 64 years proved suboptimal.

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

By Sydney Jennings

March 14th 2025

The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with T1D in a small study.

Latest CME Events & Activities

...

27 28 29 30 31

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777